# Anticholinergic Deprescription in Schizophrenia

> **NCT06562608** · PHASE4 · RECRUITING · sponsor: **Deepak K. Sarpal, M.D.** · enrollment: 105 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Anticholinergic Deprescription
- **DRUG:** No Anticholinergic Deprescription

## Key facts

- **NCT ID:** NCT06562608
- **Lead sponsor:** Deepak K. Sarpal, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-06-30
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06562608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06562608, "Anticholinergic Deprescription in Schizophrenia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06562608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*